| scholarly article | Q13442814 |
| P50 | author | Bengt Lindholm | Q63372914 |
| Olof Heimbürger | Q65927824 | ||
| Juan J Carrero | Q37828646 | ||
| Peter Stenvinkel | Q37828656 | ||
| Abdul Rashid Qureshi | Q41896648 | ||
| Peter Barany | Q51756080 | ||
| P2093 | author name string | Vallabh O Shah | |
| Dominic S C Raj | |||
| Pope L Moseley | |||
| Jennet Ferguson | |||
| P2860 | cites work | Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. | Q51918236 |
| Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions | Q52251445 | ||
| The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality | Q53496784 | ||
| CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients | Q56270973 | ||
| Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure | Q59306999 | ||
| Endotoxemia in chronic renal failure | Q68945726 | ||
| What is subjective global assessment of nutritional status? | Q69758169 | ||
| Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS | Q70847437 | ||
| Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers | Q71773881 | ||
| Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes | Q72171836 | ||
| Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study | Q73250259 | ||
| Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: possible implications for leukocyte aggregation and microvascular plugging | Q74027516 | ||
| Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite | Q79896824 | ||
| Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis | Q80740259 | ||
| Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease | Q82545353 | ||
| Lipopolysaccharide endotoxins | Q24650970 | ||
| Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years | Q28246221 | ||
| LPS-binding proteins and receptors | Q28646217 | ||
| CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 | ||
| Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? | Q33345061 | ||
| Regulation of muscle protein synthesis during sepsis and inflammation | Q34628735 | ||
| Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. | Q34683473 | ||
| Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences | Q35569527 | ||
| Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients | Q36666840 | ||
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease | Q36736700 | ||
| Cytokine dysregulation in chronic kidney disease: how can we treat it? | Q37141709 | ||
| Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters | Q37354703 | ||
| Effects of gender and sex steroids on the immune response | Q38147161 | ||
| Hemodialysis modulates gene expression profile in skeletal muscle | Q38309296 | ||
| The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin | Q40738309 | ||
| Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface | Q40917376 | ||
| CD14 is a pattern recognition receptor | Q41446610 | ||
| Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein | Q42942925 | ||
| A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease | Q43442519 | ||
| A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients | Q43812630 | ||
| CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity | Q44392922 | ||
| Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes | Q46463155 | ||
| Endotoxin induced TNF and IL-10 mRNA production is higher in male than female donors: correlation with elevated expression of TLR4. | Q46539088 | ||
| Soluble CD14 and aortic stiffness in a population-based study | Q47607256 | ||
| Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle | Q47863220 | ||
| Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival | Q47940556 | ||
| Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. | Q50614739 | ||
| Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients | Q51699280 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| interleukins | Q194908 | ||
| hemodialysis patient | Q126109077 | ||
| P304 | page(s) | 1072-1080 | |
| P577 | publication date | 2009-09-06 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients | |
| P478 | volume | 54 |
| Q87390173 | A balancing act: protein-energy wasting in chronic kidney disease |
| Q37139884 | A comparative study of blood endotoxin detection in haemodialysis patients |
| Q30234466 | Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. |
| Q38425357 | Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. |
| Q44598937 | An investigation of the role of soluble CD14 in hospitalized, sick horses. |
| Q36443224 | Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. |
| Q37079653 | Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis |
| Q36025615 | Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD. |
| Q37131182 | CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity |
| Q57025025 | Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease |
| Q54233821 | Circulating Bacterial Fragments as Cardiovascular Risk Factors in CKD. |
| Q39598955 | Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation |
| Q35983529 | Effect of Phosphate Binders on Serum Inflammatory Profile, Soluble CD14, and Endotoxin Levels in Hemodialysis Patients |
| Q38231473 | Endotoxemia in end-stage kidney disease |
| Q42718522 | Endotoxin Binding by Sevelamer: Potential Impact on Nutritional Status |
| Q44368427 | European Training and Research in Peritoneal Dialysis: scientific objectives, training, implementation and impact of the programme |
| Q38836354 | Gut microbiome in chronic kidney disease: challenges and opportunities |
| Q36383621 | HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation |
| Q64232494 | Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease |
| Q39309490 | Inflammation and premature aging in advanced chronic kidney disease |
| Q38757951 | Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options. |
| Q36169427 | Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan |
| Q36473805 | Lack of effect of the CD14 promoter gene C-159T polymorphism on nutritional status parameters in hemodialysis patients |
| Q40518328 | Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease |
| Q35024794 | Protein-energy wasting and mortality in chronic kidney disease |
| Q33613115 | Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target |
| Q35889821 | Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease |
| Q40219806 | Soluble CD14 and fracture risk |
| Q46260769 | Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis |
| Q34394336 | Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents |
| Q50872135 | Targeting Immunity in End-Stage Renal Disease |
| Q46415279 | The Chronic Kidney Disease - Colonic Axis |
| Q34789326 | The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation |
| Q35042986 | The gut microbiome, kidney disease, and targeted interventions |
| Q38012025 | The immunoregulatory function of vitamin D: implications in chronic kidney disease |
| Q37050237 | Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium |
Search more.